Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-07 | Dr. Rebecca HunterCEO & Director | 80,00k | 14,66k | Achat | 0,18 | 171,21k | 87,71% |
| 2025-12-12 | Dr. Rebecca HunterCEO & Director | -17,68k | 0,00 | Other Derivative Disposition | - | 21,21k | -45,45% |
| 2026-02-28 | Dr. Rebecca HunterCEO & Director | -1,41M | 0,00 | Other Derivative Disposition | - | 500,00k | -73,88% |
| 2026-04-06 | Mr. Charles BeaudryIndependent Director | -400,00k | 0,00 | Other Disposition | - | 100,00k | -80,00% |
| 2025-10-22 | Dr. Rebecca HunterCEO & Director | -16,97k | 0,00 | Other Disposition | - | 4,24k | -80,00% |
| 2026-04-07 | Mr. Joel FriedmanCFO | -600,00k | 0,00 | Other Derivative Disposition | - | 400,00k | -60,00% |
| 2026-01-26 | Dr. Rebecca HunterCEO & Director | 500,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,91M | 35,36% |
| 2026-01-26 | Mr. Stephen Alexander-Nelson StewartIndependent Chairman of the Board | 500,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,28 | 6,15M | 8,85% |
| 2026-01-26 | Mr. Charles BeaudryIndependent Director | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 675,00k | 8,00% |
| 2026-01-26 | Mr. James Christopher-Petterson SykesDirector | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 780,75k | 14,69% |
| 2025-10-27 | Mr. James Christopher-Petterson SykesDirector | -3,40M | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-01-26 | Ms. Janet MeiklejohnDirector | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,28 | 400,48k | 33,28% |
| 2026-01-26 | Mr. Joel FriedmanCFO | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,28 | 1 000,00k | 33,33% |
| 2025-12-04 | Dr. Rebecca HunterCEO & Director | 70,00k | 14,55k | Achat | 0,20 - 0,22 | 91,21k | 330,03% |
| 2025-08-29 | Dr. Rebecca HunterCEO & Director | 247,45k | 0,00 | Open Market Derivative Acquisition | 0,55 - 1,39 | 282,80k | 700,00% |
| 2025-08-29 | Dr. Rebecca HunterCEO & Director | 7,78k | 0,00 | Open Market Derivative Acquisition | 1,54 - 1,90 | 7,78k | - |
| 2025-08-29 | Dr. Rebecca HunterCEO & Director | 21,21k | 0,00 | Achat | - | 21,21k | - |
| 2025-08-29 | Dr. Rebecca HunterCEO & Director | 35,35k | 0,00 | Open Market Derivative Acquisition | 1,03 | 212,10k | 20,00% |
| 2025-08-15 | Mr. Stephen Alexander-Nelson StewartIndependent Chairman of the Board | 214,36k | 72,21k | Achat | 0,34 | 469,14k | 84,14% |
| 2025-06-30 | Mr. James Christopher-Petterson SykesDirector | 20,00k | 7,70k | Achat | 0,38 | 156,75k | 14,63% |
| 2025-06-05 | Mr. James Christopher-Petterson SykesDirector | 50,75k | 18,59k | Derivative Exercise and Retained Stock | 0,37 | 136,75k | 59,01% |
| 2025-06-05 | Mr. James Christopher-Petterson SykesDirector | -149,25k | 0,00 | Other Derivative Disposition | - | 680,75k | -17,98% |
| 2025-06-05 | Mr. Charles BeaudryIndependent Director | -25,37k | 0,00 | Derivative Exercise and Sale | 0,37 | 100,00k | - |
| 2025-06-03 | Mr. Stephen Alexander-Nelson StewartIndependent Chairman of the Board | 76,12k | 27,74k | Achat | 0,36 | 254,77k | 42,61% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.